Is RUBNF or JNJ a better dividend investment in 2026?

RUBNF currently yields 4000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: RUBNF offers higher current income.

What is the dividend yield difference between RUBNF and JNJ?

RUBNF has a forward dividend yield of 4000.00% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 3997.87 percentage points.

Home › Compare › RUBNF vs JNJ

RUBNF vs JNJ: Dividend Comparison 2026

RUBNF yields 4000.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RUBNF wins by $7175340620755.84M in total portfolio value

INVESTMENT

TIME HORIZON10 years

RUBNF

● Live price

4000.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7175340620755.87M

Annual income

$6,839,006,593,197,835,000.00

Full RUBNF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — RUBNF vs JNJ

📍 RUBNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RUBNF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RUBNF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RUBNF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RUBNF

Annual income on $10K today (after 15% tax)

$340,000.00/yr

After 10yr DRIP, annual income (after tax)

$5,813,155,604,218,160,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, RUBNF beats the other by $5,813,155,604,218,156,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RUBNF + JNJ for your $10,000?

RUBNF: 50%JNJ: 50%

100% JNJ50/50100% RUBNF

Portfolio after 10yr

$3587670310377.95M

Annual income

$3,419,503,296,598,920,000.00/yr

Blended yield

95.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RUBNF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

0.3

Piotroski

4/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RUBNF buys

JNJ buys

No recent congressional trades found for RUBNF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRUBNFJNJ

Forward yield	4000.00% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$7175340620755.87M ✓	$30.3K
Annual income after 10y	$6,839,006,593,197,835,000.00 ✓	$4,689.40
Total dividends collected	$7152397773804.84M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Hold	Buy

Year-by-year: RUBNF vs JNJ ($10,000, DRIP)

Year	RUBNF Portfolio	RUBNF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$410,700	$400,000.00	$10,592	$272.30	+$400.1K → RUBNF
2	$15,792,720	$15,353,271.03	$11,289	$357.73	+$15.78M → RUBNF
3	$568,657,142	$551,758,931.89	$12,123	$472.89	+$568.65M → RUBNF
4	$19,176,207,860	$18,567,744,718.20	$13,141	$629.86	+$19176.19M → RUBNF
5	$605,696,028,890	$585,177,486,479.73	$14,408	$846.81	+$605696.01M → RUBNF
6	$17,922,210,653,594	$17,274,115,902,681.27	$16,021	$1,151.60	+$17922210.64M → RUBNF
7	$496,869,793,504,300	$477,693,028,104,954.00	$18,122	$1,588.22	+$496869793.49M → RUBNF
8	$12,908,672,105,251,704	$12,377,021,426,202,104.00	$20,930	$2,228.20	+$12908672105.23M → RUBNF
9	$314,330,866,876,668,540	$300,518,587,724,049,200.00	$24,792	$3,191.91	+$314330866876.64M → RUBNF
10	$7,175,340,620,755,871,000	$6,839,006,593,197,835,000.00	$30,274	$4,689.40	+$7175340620755.84M → RUBNF

RUBNF vs JNJ: Complete Analysis 2026

RUBNF — Stock

ArborGen Holdings Limited engages in the forestry genetics business. It provides its tree seedlings under the ArborGen brand name to forestry industry primarily in the United States and Brazil. The company was formerly known as Rubicon Limited and changed its name to ArborGen Holdings Limited in September 2019. ArborGen Holdings Limited was incorporated in 2001 and is based in Auckland, New Zealand.

Full RUBNF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this RUBNF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RUBNF vs SCHD RUBNF vs JEPI RUBNF vs O RUBNF vs KO RUBNF vs MAIN RUBNF vs ABBV RUBNF vs MRK RUBNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.